Structure (Divalproex Sodium De Figure 1)
Divalproex Sodium Tablet, Delayed Release
Product Images NDC 82804-233
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 82804-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Divalproex Sodium De Figure 2)
Figure2 (Divalproex Sodium De Figure 3)
Figure3 (Divalproex Sodium De Figure 4)
Figure4 (Divalproex Sodium De Figure 5)
82804-233-30 (Image 01)
This is a description of Divalproex sodium tablets with a dosage of 250 mg. Each tablet is enteric-coated and delayed-release. The tablets are pale brown with a mottled appearance, modified oval biconvex shape. They are imprinted with "512" on one side in black ink. The product is distributed by Bionpharma Inc. and made in India. The tablets are packaged by Proficient Rx LP in Thousand Oaks, CA. The NDC for this product is 82804-233-30. It is necessary to dispense the Medication Guide provided separately to each patient. The storage instructions recommend keeping the medication at 20°-25°C (68°-77°F) and out of reach of children. The lot number is mentioned as 00000 and the expiration date is 00/00/00. Additionally, the GTIN is provided as 00382804233304.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
